{"id":"F2005L02115","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 15 of 2005)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":36387,"registerId":"commonwealth-F2005L02115-current","compilationNumber":null,"startDate":"2026-04-01","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 15 of 2005)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 15 of 2005\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 August 2005.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAltretamine\n\nFerrous Gluconate\n\nFusidic Acid\n\nInsulin Zinc Suspension\n\nInsulin Zinc Suspension (Crystalline)\n\nRibavirin and Interferon Alfa-2b\n\nThiamine Hydrochloride\n\nDated this twenty sixth day of July 2005.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2918},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration remains precisely focused on its original purpose of delisting specific pharmaceutical benefits from the PBS. It has not expanded beyond the seven specific drugs identified in the schedule."},"complexity_factors":["Single operative provision with straightforward directive","7 specific drug items listed in schedule (no categorical definitions or classes)","Requires understanding of Part VII of the National Health Act 1953 (PBS provisions)","No conditional language, exceptions, or procedural requirements"],"plain_english_summary":"This instrument removes seven specific medicines from the Pharmaceutical Benefits Scheme, meaning they no longer receive PBS subsidies and patients must pay full private prices. Affected products include older insulins, some antimicrobials, supplements and certain cancer/viral treatments.\n\nClinicians and pharmacists may need to shift patients to PBS-listed alternatives; the change reflects replacement by newer or rarely used medicines and took effect 1 August 2005."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2005/documents"}}